ResearcherScience for Life LaboratoryNo recent work listed
Anna Orlova
Matched on ORCID iD 0000-0001-6120-2683; OpenAlex author ID A5014071440.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 2
- Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model. Co-author DOI 10.3390/ijms24032838↗
- Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model. Last author DOI 10.3390/pharmaceutics12060551↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Tianqi Xu · 1 shared paper, 2023
- Anzhelika Vorobyeva · 1 shared paper, 2023
- Charles Dahlsson Leitao · 1 shared paper, 2020
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.